$GEVO

Gruber Patrick R. sold $374K of GEVO

Gruber Patrick R. sold 247,642 shares of Gevo, Inc. (GEVO) at $1.51 ($0.37M total) on 2026-08-06 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Gruber Patrick R.
Published Aug 7, 2026, 9:22 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 9:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$GEVO
Neutral
medium confidence
Mentioned
$GEVO
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GEVONeutralLow
01

Why it matters

The only new information is the reported sale size, price, and post-transaction holdings; no new company-specific fundamentals are provided.

02

Market read

Traders may monitor for follow-on insider activity, but this filing alone is unlikely to drive a major repricing without accompanying company news.

03

What to watch

The filing does not state any change in business outlook, guidance, or risk factors; traders should avoid extrapolating fundamentals from a single planned sale.

Relevance 3/10Novelty 3/10Timing: SEC Form 4 filed after-hours on 2026-08-07, covering a sale dated 2026-08-06.

Background

The article is an SEC Form 4 insider transaction disclosure for Gevo, Inc., reporting a director’s open-market sale under a 10b5-1 plan.

Company-level read

Ticker impact

$GEVONeutralMedium confidence
Context

Form 4 shows director Patrick R. Gruber sold 247,642 shares of Gevo at $1.5095 on 2026-08-06 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any impact is likely limited to short-term sentiment around insider selling.

Evidence & confidence

The filing is a routine 10b5-1 open-market sale by a director, with no accompanying operational, financial, or regulatory catalyst disclosed in the text.

Market effects

Minimal. Insider-sale disclosures typically do not reset sector fundamentals.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect diversification or liquidity needs rather than bearish expectations.

Key entities

  • Gevo, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Patrick R. Gruber

    Director who sold 247,642 shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$GEVOMedAI 8/10

Gevo (GEVO) Q2 2026 Earnings Call Transcript

Gevo (GEVO) reported Q2 2026 revenue of $47 million, up 7% year over year, and non-GAAP adjusted EBITDA of $11 million. Full-year 2026 adjusted EBITDA guidance is now above $60 million. The company targets $70 million of 45Z tax credit monetization in 2026 and recorded a $176 million noncash impairment tied to exiting its ATJ-60 project.

$GEVOHigh

Gevo, Inc. (GEVO): Results of Operations and Financial Condition

Gevo, Inc. (GEVO) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Gevo Reports Second Quarter Results and Raises Financial Expectations for Full-Year 2026 ENGLEWOOD, Colo. – August 6, 2026 – Gevo, Inc. (NASDAQ: GEVO), a leader in renewable fuels, chemicals and carbon management, today announced its financial results for the second

$GEVOMedAI 8/10

Why Is Gevo (GEVO) Stock Rocketing Higher Today

Gevo (NASDAQ: GEVO) shares rose about 7.5% after the company said it expects 2026 non-GAAP Adjusted EBITDA to be more than double prior estimates. Gevo attributed the upgrade to new carbon pathways, higher production, and cost reductions, and it announced Todd Werpy, Ph.D., joining its board. The stock is volatile and trades at $1.68.